Cell transplantation to repair the injured spinal cord.
作者信息
Hall Adam, Fortino Tara, Spruance Victoria, Niceforo Alessia, Harrop James S, Phelps Patricia E, Priest Catherine A, Zholudeva Lyandysha V, Lane Michael A
机构信息
Drexel University, Philadelphia, PA, United States; Marion Murray Spinal Cord Research Center, Drexel University, Philadelphia, PA, United States.
Drexel University, Philadelphia, PA, United States; Marion Murray Spinal Cord Research Center, Drexel University, Philadelphia, PA, United States; Division of Kidney, Urologic, & Hematologic Diseases, National Institutes of Health, Bethesda, MD, United States.
出版信息
Int Rev Neurobiol. 2022;166:79-158. doi: 10.1016/bs.irn.2022.09.008. Epub 2022 Nov 9.
Abstract
摘要
相似文献
1
Cell transplantation to repair the injured spinal cord.
Int Rev Neurobiol. 2022;166:79-158. doi: 10.1016/bs.irn.2022.09.008. Epub 2022 Nov 9.
2
Endothelial progenitor cells promote astrogliosis following spinal cord injury through Jagged1-dependent Notch signaling.
J Neurotrauma. 2012 Jun 10;29(9):1758-69. doi: 10.1089/neu.2011.2139. Epub 2012 May 21.
3
Altered differentiation of CNS neural progenitor cells after transplantation into the injured adult rat spinal cord.
Cell Transplant. 1997 May-Jun;6(3):327-38. doi: 10.1177/096368979700600315.
4
[Research progression of tissue transplantation and functional reconstruction of spinal cord].
Zhongguo Gu Shang. 2008 Jun;21(6):483-5.
5
Transplanted neural progenitor cells survive and differentiate but achieve limited functional recovery in the lesioned adult rat spinal cord.
Regen Med. 2007 Nov;2(6):929-45. doi: 10.2217/17460751.2.6.929.
6
From transplanting Schwann cells in experimental rat spinal cord injury to their transplantation into human injured spinal cord in clinical trials.
Prog Brain Res. 2017;231:107-133. doi: 10.1016/bs.pbr.2016.12.012. Epub 2017 Mar 31.
7
Transplantation of preconditioned Schwann cells following hemisection spinal cord injury.
Spine (Phila Pa 1976). 2007 Apr 20;32(9):943-9. doi: 10.1097/01.brs.0000261408.61303.77.
8
Transplantation of Human umbilical cord mesenchymal stem cells promotes functional recovery after spinal cord injury by blocking the expression of IL-7.
Eur Rev Med Pharmacol Sci. 2018 Oct;22(19):6436-6447. doi: 10.26355/eurrev_201810_16056.
9
What is the potential of oligodendrocyte progenitor cells to successfully treat human spinal cord injury?
BMC Neurol. 2011 Sep 23;11:113. doi: 10.1186/1471-2377-11-113.
10
Percutaneous endoscopic cellular transplantation into the lower lumbar spinal cord.
Neurosurgery. 2004 Apr;54(4):950-5; discussion 955. doi: 10.1227/01.neu.0000115673.14729.7d.
引用本文的文献
1
Exosome-Loaded Bioscaffolds for Spinal Cord Injuries: A Review.
Stem Cells Int. 2025 Jul 30;2025:8841129. doi: 10.1155/sci/8841129. eCollection 2025.
2
Analysis of astrocyte progenitors derived from human induced pluripotent stem cells and following transplantation into the intact spinal cord.
bioRxiv. 2025 Jun 28:2025.06.27.661961. doi: 10.1101/2025.06.27.661961.
3
Schwann cells in regeneration and cancer.
Front Pharmacol. 2025 Jan 29;16:1506552. doi: 10.3389/fphar.2025.1506552. eCollection 2025.
4
Challenges and Efficacy of Astrocyte-to-Neuron Reprogramming in Spinal Cord Injury: In Vitro Insights and In Vivo Outcomes.
bioRxiv. 2025 Jan 21:2024.03.25.586619. doi: 10.1101/2024.03.25.586619.
5
Hydrogel-encapsulated extracellular vesicles for the regeneration of spinal cord injury.
Front Neurosci. 2023 Dec 14;17:1309172. doi: 10.3389/fnins.2023.1309172. eCollection 2023.
6
Schwann Cell-Derived Exosomal Vesicles: A Promising Therapy for the Injured Spinal Cord.
Int J Mol Sci. 2023 Dec 10;24(24):17317. doi: 10.3390/ijms242417317.
7
Therapeutic Strategies Targeting Respiratory Recovery after Spinal Cord Injury: From Preclinical Development to Clinical Translation.
Cells. 2023 May 31;12(11):1519. doi: 10.3390/cells12111519.
本文引用的文献
1
NPC transplantation rescues sci-driven cAMP/EPAC2 alterations, leading to neuroprotection and microglial modulation.
Cell Mol Life Sci. 2022 Jul 29;79(8):455. doi: 10.1007/s00018-022-04494-w.
2
Grafted human ESC-derived astroglia repair spinal cord injury via activation of host anti-inflammatory microglia in the lesion area.
Theranostics. 2022 May 16;12(9):4288-4309. doi: 10.7150/thno.70929. eCollection 2022.
3
Cell-based and stem-cell-based treatments for spinal cord injury: evidence from clinical trials.
Lancet Neurol. 2022 Jul;21(7):659-670. doi: 10.1016/S1474-4422(21)00464-6. Epub 2022 May 12.
4
Administration of C5a Receptor Antagonist Improves the Efficacy of Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in the Acute Phase of Spinal Cord Injury.
J Neurotrauma. 2022 May;39(9-10):667-682. doi: 10.1089/neu.2021.0225.
5
Transneuronal tracing to map connectivity in injured and transplanted spinal networks.
Exp Neurol. 2022 May;351:113990. doi: 10.1016/j.expneurol.2022.113990. Epub 2022 Jan 25.
6
Modulation by DREADD reveals the therapeutic effect of human iPSC-derived neuronal activity on functional recovery after spinal cord injury.
Stem Cell Reports. 2022 Jan 11;17(1):127-142. doi: 10.1016/j.stemcr.2021.12.005.
7
Considering the Cellular Composition of Olfactory Ensheathing Cell Transplants for Spinal Cord Injury Repair: A Review of the Literature.
Front Cell Neurosci. 2021 Nov 17;15:781489. doi: 10.3389/fncel.2021.781489. eCollection 2021.
8
Long-term selective stimulation of transplanted neural stem/progenitor cells for spinal cord injury improves locomotor function.
Cell Rep. 2021 Nov 23;37(8):110019. doi: 10.1016/j.celrep.2021.110019.
9
LOTUS overexpression via ex vivo gene transduction further promotes recovery of motor function following human iPSC-NS/PC transplantation for contusive spinal cord injury.
Stem Cell Reports. 2021 Nov 9;16(11):2703-2717. doi: 10.1016/j.stemcr.2021.09.006. Epub 2021 Oct 14.
10
First-in-human clinical trial of transplantation of iPSC-derived NS/PCs in subacute complete spinal cord injury: Study protocol.
Regen Ther. 2021 Sep 7;18:321-333. doi: 10.1016/j.reth.2021.08.005. eCollection 2021 Dec.
Zotero 插件